Current Developments in Psychopharmacology PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Current Developments in Psychopharmacology PDF full book. Access full book title Current Developments in Psychopharmacology by . Download full books in PDF and EPUB format.
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 491
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 491
Get Book Here
Book Description
Author: Ian Stolerman
Publisher: Springer Science & Business Media
ISBN: 3540686983
Category : Medical
Languages : en
Pages : 1433
Get Book Here
Book Description
Here is a broad overview of the central topics and issues in psychopharmacology, biological psychiatry and behavioral neurosciences, with information about developments in the field, including novel drugs and technologies. The more than 2000 entries are written by leading experts in pharmacology and psychiatry and comprise in-depth essays, illustrated with full-color figures, and are presented in a lucid style.
Author: W.B. Essman
Publisher: Springer Science & Business Media
ISBN: 9401181233
Category : Medical
Languages : en
Pages : 287
Get Book Here
Book Description
The areas of experimental and clinical psychopharmacology have continued to grow in terms of the numbers of studies appearing in the literature as well as the activity generated by other disciplines that has influenced the output of behavioral pharmacology research. Psychoactive drugs have been considered for their comparative effects upon selected behaviors or for their effect upon diverse behaviors. Behavioral circum stances certainly influence not only the metabolism and action of psycho tropic drugs behaviorally, but also the disposition of these agents and/ or their metabolites in regions of the central nervous system. There can hardly be a psychopharmacology without a neuropharmacology, and the latter would seem to depend upon a neurochemistry. There would appear to be variables that exert potent influences upon the disposition and action of psychotropic drugs, that also relate quite directly to their effects upon behavior; these include drug interactions, nutritional status, environmental effects such as temperature, photic and tactile stimulation, and stress, and the basal status upon which such drug treatment is superimposed. In this volume of Current Developments in Psychopharmacology, which will be the last to appear in this format, we have sought to focus upon a series of current topical reviews that highlight representative areas of experimental and clinical research activity in psychopharmacology. In the first chapter, Dr. Lagerspetz reviews a frequently neglected aspect of psychopharmacological research-the actions of psychoactive agents upon the nervous system and behavior of non-mammalian species.
Author: René Spiegel
Publisher: John Wiley & Sons
ISBN: 0470869461
Category : Medical
Languages : en
Pages : 420
Get Book Here
Book Description
Describes the latest advances in psychopharmacology - one of the most rapidly developing fields in modern science. This latest edition has been updated to cover new developments in drug therapy and research including newly introduced antipsychotics, antidepressants and antidementia drugs. Sections on the treatment of depression and dementia have been revised to include new developments in treatment strategies. It will be welcomed for its essentially clinical and psychological approach to modern pharmaceuticals, their therapeutic uses and limitations, adverse reactions and future directions for research.
Author: H. Paul Putman III, M.D., DLFAPA
Publisher: American Psychiatric Pub
ISBN: 1615373136
Category : Medical
Languages : en
Pages : 336
Get Book Here
Book Description
"Most books about psychopharmacology focus heavily on the basic science involved and describe the currently available medications, including brief rationales for their use as well as their dosages and their side effects. Others are more for the general public, intended to help them understand how psychopharmacology might be helpful. This book is different. The goal is to teach the reader what medicines are available and what their characteristics are as well as teach very valuable skills: how to think thoroughly and methodically when assessing a patient, when reviewing research data (both basic and clinical), and when thinking through, developing, and monitoring the most effective clinical recommendations for patients. Rather than a lesson in elementary patient assessment, this book is an attempt to help readers identify weaknesses in their practice style and improve them where psychopharmacology is involved"--
Author: Walter B. Essman
Publisher:
ISBN:
Category : Psychopharmacology
Languages : en
Pages : 248
Get Book Here
Book Description
Author: David Healy
Publisher: Harvard University Press
ISBN: 9780674038455
Category : Medical
Languages : en
Pages : 484
Get Book Here
Book Description
David Healy follows his widely praised study, The Antidepressant Era, with an even more ambitious and dramatic story: the discovery and development of antipsychotic medication. Healy argues that the discovery of chlorpromazine (more generally known as Thorazine) is as significant in the history of medicine as the discovery of penicillin, reminding readers of the worldwide prevalence of insanity within living memory. But Healy tells not of the triumph of science but of a stream of fruitful accidents, of technological discovery leading neuroscientific research, of fierce professional competition and the backlash of the antipsychiatry movement of the 1960s. A chemical treatment was developed for one purpose, and as long as some theoretical rationale could be found, doctors administered it to the insane patients in their care to see if it would help. Sometimes it did, dramatically. Why these treatments worked, Healy argues provocatively, was, and often still is, a mystery. Nonetheless, such discoveries made and unmade academic reputations and inspired intense politicking for the Nobel Prize. Once pharmaceutical companies recognized the commercial potential of antipsychotic medications, financial as well as clinical pressures drove the development of ever more aggressively marketed medications. With verve and immense learning, Healy tells a story with surprising implications in a book that will become the leading scholarly work on its compelling subject.
Author: Peter M. Haddad
Publisher:
ISBN: 9781911623465
Category :
Languages : en
Pages :
Get Book Here
Book Description
"The 2nd edition of this book was edited by David King and published in 2004. Since then there have been major advances in psychopharmacology in terms of new medications coming to the market, increased understanding of the mechanisms of drug action and new data on the efficacy, tolerability, safety and clinical effectiveness of a range of medications. Partly as a result, clinical guidelines for many psychiatric disorders have altered. As such, a new edition of this textbook was essential and we were delighted when the College approached us to edit the 3rd edition. This was a major endeavor that was only possible with the commitment and expertise of the authors"--
Author: Olivier
Publisher: Birkhäuser
ISBN: 3034864191
Category : Science
Languages : en
Pages : 447
Get Book Here
Book Description
Author: Daniel E. Casey
Publisher: Springer Science & Business Media
ISBN: 3642732801
Category : Medical
Languages : en
Pages : 326
Get Book Here
Book Description
The landmark description by Delay and Deniker in 1952 of chlorpromazine's effect in psychosis suddenly eclipsed all other progress in psychopharmacology over the previous centuries. Since this report 35 years ago, a vast amount of research has contributed to the major advances in treatment that have improved the lives of millions of patients who would otherwise be incapacitated by their psychiatric disorders. This research has also led to valuable new insights into the causes of mental illnesses and the mechanisms of action of therapeutic drugs. However, there is much more work to be done. Thus, it is of great value periodically to assess the present state of knowledge as a first step to charting future directions. This symposium held in Denmark in 1987 covered many critical issues in psychopharmacology. The etiology, pathogenetic mechanisms, clinical aspects, and future directions of research in schizophrenia, affective disorders, anxiety, and dementia are addressed. Several of the problems with current therapeutic agents, such as side effects and limited efficacy, are also reviewed. Preclinical strategies with existing and new animal and computer models are discussed to point the way for developing better psychopharmacologic treatments of all psychiatric disorders.
